Loading…
Prostate Cancer Misdiagnosis Elimination Act of 2016
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
57pct
19d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Prostate Cancer Misdiagnosis Elimination Act of 2016 This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2016 · fourth_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R.5763 - Prostate Cancer Misdiagnosis Elimination Act of 2016.
Client expense: Not reported · Firm income: $20,000
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Congress.gov source codes: H11100, H11100-A
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Medicare/Medicaid
Medicare coverage of diagnostic test. Support for H.R.5763 - Prostate Cancer Misdiagnosis Elimination Act of 2016.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE